Baxter International Inc. (BAX)
Makes IV fluids, infusion devices, and injectable medicines for hospitals and home care
$23.34+0.04%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+6.3%
The outlook
Baxter is trading above both its 50- and 200-day moving averages, putting it in a positive technical position within its 52-week range. Analyst sentiment leans neutral-to-hold, with the average price target sitting about 6% below the current price. The overall scorecard suggests a cautiously bullish lean, though coverage opinion remains mixed.
What’s behind the score
Analyst consensusHold — 2.8 avg of 11 analysts
Price trendAbove its 50- & 200-day averages
52-week range57% of the way from its 52-week low to high
Price targetAvg target -6% vs current price
Analyst price target
~12-month · 11 analysts$21.95average target-5.9% vs now
Now $23.34
Low $17.00High $40.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$12.05B
52-wk high
$29.00
52-wk low
$15.73
50-day avg
$20.62
200-day avg
$19.51
Trailing P/E
—